Methotrexate vs Pembrolizumab
Methotrexate vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Methotrexate and Pembrolizumab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Pembrolizumab β 26 days.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Pembrolizumab β Antibody.